Page
%P
-
Article
Open AccessSiglec-5 is a novel marker of critical limb ischemia in patients with diabetes
Critical Limb Ischemia (CLI) is common but uncommonly diagnosed. Improved recognition and early diagnostic markers for CLI are needed. Therefore, the aim of our study was to identify plasma biomarkers of CLI i...